BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

927 related articles for article (PubMed ID: 11231853)

  • 1. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.
    Heslin MJ; Medina-Franco H; Parker M; Vickers SM; Aldrete J; Urist MM
    Arch Surg; 2001 Mar; 136(3):318-23. PubMed ID: 11231853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.
    Martin RC; Edwards MJ; McMasters KM
    Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.
    Buisman FE; Grünhagen DJ; Homs MYV; Grootscholten C; Filipe WF; Kemeny NE; Cercek A; D'Angelica MI; Donswijk ML; van Doorn L; Emmering J; Jarnagin WR; Kingham TP; Klompenhouwer EG; Kok NFM; Kuiper MC; Moelker A; Prevoo W; Versleijen MWJ; Verhoef C; Kuhlmann KFD; Groot Koerkamp B
    Ann Surg Oncol; 2019 Dec; 26(13):4599-4607. PubMed ID: 31641947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
    BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer.
    Miyanari N; Mori T; Takahashi K; Yasuno M
    Dis Colon Rectum; 2002 Nov; 45(11):1503-9. PubMed ID: 12432299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy.
    Martin RC; Scoggins CR; McMasters KM
    J Surg Oncol; 2006 Apr; 93(5):387-93. PubMed ID: 16550574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
    Yan TD; Padang R; Morris DL
    J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
    N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.
    Muaddi H; D'Angelica M; Wiseman JT; Dillhoff M; Latchana N; Roke R; Ko YJ; Carpizo D; Spencer K; Fields RC; Williams G; Aucejo F; Acevedo-Moreno LA; Billingsley KG; Walker BS; Mayo SC; Karanicolas PJ
    J Surg Oncol; 2021 Jan; 123(1):252-260. PubMed ID: 33095919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.
    Buisman FE; Filipe WF; Kemeny NE; Narayan RR; Srouji RM; Balachandran VP; Boerner T; Drebin JA; Jarnagin WR; Kingham TP; Wei AC; Grünhagen DJ; Verhoef C; Koerkamp BG; D'Angelica MI
    Ann Surg Oncol; 2021 Feb; 28(2):808-816. PubMed ID: 32648182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.
    Chakedis J; Beal EW; Sun S; Galo J; Chafitz A; Davidson G; Reardon J; Dillhoff M; Pawlik TM; Abdel-Misih S; Bloomston M; Schmidt CR
    J Surg Oncol; 2018 Dec; 118(7):1065-1073. PubMed ID: 30376157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous liver resection and cryotherapy for colorectal metastases: survival analysis.
    Brooks AJ; Wang F; Alfredson M; Yan TD; Morris DL
    Surgeon; 2005 Aug; 3(4):265-8. PubMed ID: 16121772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy.
    Preketes AP; Caplehorn JR; King J; Clingan PR; Ross WB; Morris DL
    World J Surg; 1995; 19(5):768-71. PubMed ID: 7571679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary resection and synchronous regional hepatic chemotherapy or cryotherapy for colorectal cancer with liver metastases.
    Dasappa V; Ross WB; King J; King DW; Clingan PR; Morris DL
    Int J Colorectal Dis; 1996; 11(1):38-41. PubMed ID: 8919340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil.
    Bilchik AJ; Wood TF; Chawla SP; Rose DM; Chung MH; Stern SS; Foshag LJ; Ramming KP
    Clin Colorectal Cancer; 2001 May; 1(1):36-42. PubMed ID: 12445377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of survival following hepatic resection for metastatic colorectal cancer.
    Bakalakos EA; Kim JA; Young DC; Martin EW
    World J Surg; 1998 Apr; 22(4):399-404; discussion 404-5. PubMed ID: 9523523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical therapy of liver metastases. Therapeutic procedures, results and prognostic factors].
    Riesener KP; Winkeltau G; Klemm M; Schumpelick V
    Langenbecks Arch Chir; 1994; 379(6):321-8. PubMed ID: 7845156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases.
    Litvak DA; Wood TF; Tsioulias GJ; Chung M; Chawla SP; Foshag LJ; Morton DL; Ramming KP; Bilchik AJ
    Ann Surg Oncol; 2002 Mar; 9(2):148-55. PubMed ID: 11888871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.